Tg Therapeutics reported $70.04M in Debt for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Debt Change
Amgen AMGN:US USD 38.7B 2.18B
Ardelyx ARDX:US USD 26.54M 168K
Bayer BAYN:GR EUR 44.79B 157M
Biogen BIIB:US USD 6.28B 998M
Intercept Pharmaceuticals ICPT:US USD 332.31M 381.55M
Karyopharm Therapeutics KPTI:US USD 302.89M 201K
Novartis NOVN:VX USD 28.44B 2.59B
Novavax NVAX:US USD 438.09M 10.34M
Ptc Therapeutics PTCT:US USD 1.06B 145.39M
Puma Biotechnology PBYI:US USD 97.99M 312K
Regeneron Pharmaceuticals REGN:US USD 2.7B 400K
Tg Therapeutics TGTX:US USD 70.04M 1.09M
Verastem VSTM:US USD 24.67M 129K
Vertex Pharmaceuticals VRTX:US USD 442.3M 40M
Ziopharm Oncology ZIOP:US USD 22.67M 1.86M